The FDA grossly overestimated the number of coronavirus diagnostic tests that would be available this week as well as U.S. laboratories’ capacity to process them, according to a report in the New York Times.
FDA commissioner Stephen Hahn told reporters on Monday that the agency’s decision allowing private labs to make their own tests would broaden their capacity to perform those tests, the Times report said.